Skip to main content

Table 6 Diagnostic ability of PJC for malignant IPMNs (HRS and WF patients)

From: The efficacy of pancreatic juice cytology with liquid-based cytology for evaluating malignancy in patients with intraductal papillary mucinous neoplasm

  

Sensitivity, (%)

Specificity, (%)

PPV, (%)

NPV, (%)

Accuracy, (%)

HRS

      

 Smear method

(n = 23)

29 (5/17)

83 (5/6)

83 (5/6)

29 (5/17)

43 (10/23)

 LBC

(n = 23)

38 (5/13)

100 (10/10)

100 (5/5)

56 (10/18)

65 (15/23)

 All patients

(n = 46)

33 (10/30)

94 (15/16)

91 (10/11)

43 (15/35)

54 (25/46)

WF

      

 Smear method

(n = 29)

9 (1/11)

100 (18/18)

100 (1/1)

64 (18/28)

66 (19/29)

 LBC

(n = 15)

50 (1/2)

100 (13/13)

100 (1/1)

93 (13/14)

93 (14/15)

 All patients

(n = 44)

15 (2/13)

100 (31/31)

100 (2/2)

74 (31/42)

75 (33/44)

  1. PJC, pancreatic juice cytology; IPMN, intraductal papillary mucinous neoplasm; HRS, high-risk stigmata; WF, worrisome features; PPV, positive predictive value; NPV, negative predictive value. LBC, liquid-based cytology